Overview

T-cell growth factor


Related Overviews

 

'T-cell growth factor' can also refer to...

T-cell growth factor

T‐cell growth factor

Abrogated transforming growth factor beta receptor II (TGFβRII) signalling in dendritic cells promotes immune reactivity of T cells resulting in enhanced atherosclerosis

Simian Immunodeficiency virus-Induced Lymphatic Tissue Fibrosis Is Mediated by Transforming Growth Factor β1-positive Regulatory T Cells and Begins in Early Infection

Transforming growth factor‐β inhibits human antigen‐specific CD4+ T cell proliferation without modulating the cytokine response

Development of CD25+ T cells secreting transforming growth factor‐β1 by altered peptide ligands expressed as self‐antigens

Acquisition of anergic and suppressive activities in transforming growth factor-β-costimulated CD4+CD25− T cells

Early growth response proteins (EGR) and nuclear factors of activated T cells (NFAT) form heterodimers and regulate proinflammatory cytokine gene expression

Astragalus polysaccharides enhance the humoral and cellular immune responses of hepatitis B surface antigen vaccination through inhibiting the expression of transforming growth factor β and the frequency of regulatory T cells

Expression of the Cholera Toxin B Subunit in the Golgi Apparatus of Swiss 3T3 Cells Inhibits DNA Synthesis Induced by Basic Fibroblast Growth Factor

Dominance of CD86, Transforming Growth Factor-β1, and Interleukin-10 in Mycobacterium tuberculosis Secretory Antigen-Activated Dendritic Cells Regulates T Helper 1 Responses to Mycobacterial Antigens

Anti-GM3 antibodies activate calcium inflow and inhibit platelet-derived growth factor beta receptors (PDGFβr) in T51B rat liver epithelial cells

Predictive factors for T790M mutation in plasma in patients after progression to 1st line tyrosine-kinase inhibitor (TKI) with or without subsequent lines of TKI or chemotherapy for metastatic epidermal growth factor receptor (EGFR)-mutated non-small-cell lung cancer (NSCLC)

Mechanisms of tolerance induced by transforming growth factor‐β‐treated antigen‐presenting cells: CD8 regulatory T cells inhibit the effector phase of the immune response in primed mice through a mechanism involving Fas ligand

476TiPPhase II study of BI1482694 in patients (pts) with T790M-positive non-small cell lung cancer (NSCLC) after treatment with an epidermal growth factor receptor tyrosine kinase inhibitor (EGFR TKI)

The elevated ratio of interferon gamma-/ interleukin-4-positive T cells found in synovial fluid and synovial membrane of rheumatoid arthritis patients can be changed by interleukin-4 but not by interleukin-10 or transforming growth factor beta

 

More Like This

Show all results sharing this subject:

  • Chemistry

GO

Show Summary Details

Quick Reference

abbr.: TCGF; an alternative name for interleukin 2.

Subjects: Chemistry.


Reference entries

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.